{
    "analytics_identifier":  null,
    "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf-if-the-uk-leaves-the-eu-w",
    "content_id":  "9ab63128-495b-494f-8c43-b317f1fa5efc",
    "description":  "Pharmacovigilance system requirements if there is a no-deal Brexit.",
    "details":  {
                    "attachments":  [
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/pdf",
                                            "file_size":  588739,
                                            "filename":  "Submission_Timeframes_Overview.pdf",
                                            "id":  "4018048",
                                            "number_of_pages":  1,
                                            "title":  "diagram which has an overview of the timeframes for submitting SPS details to the MHRA",
                                            "url":  "https://assets.publishing.service.gov.uk/media/5e3957e4ed915d09378bf6d5/Submission_Timeframes_Overview.pdf"
                                        }
                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\n\u003cp\u003eThe following legal obligations will apply to marketing authorisation holders (\u003cabbr title=\"marketing authorisation holder\"\u003eMAH\u003c/abbr\u003e) in the UK, in a no deal scenario:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eTo operate a pharmacovigilance system for UK authorised products.\u003c/li\u003e\n  \u003cli\u003eTo have an appropriately qualified person responsible for pharmacovigilance (\u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e) that resides and operates in the UK and is responsible for the establishment and maintenance of the pharmacovigilance system for UK authorised products (“the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e”).\u003c/li\u003e\n  \u003cli\u003eTo maintain and make available upon request a pharmacovigilance system master file (\u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e) that describes the pharmacovigilance system for UK authorised products (“the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e”). The UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e must be located in, or accessible electronically from, the UK at the same site at which adverse reaction reports may be accessed.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eThe purpose of this guidance is to provide practical information and instructions to UK \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e on:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003ethe role and responsibilities of the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e\n\u003c/li\u003e\n  \u003cli\u003ethe development and registration of the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and\u003c/li\u003e\n  \u003cli\u003ethe notification of the summary of pharmacovigilance system to the Medicines and Healthcare products Regulatory Agency (\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e).\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"guidance-on-the-uk-qppv\"\u003eGuidance on the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003ch3 id=\"role-and-responsibilities-of-the-uk-qppv\"\u003eRole and responsibilities of the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eThe role and responsibilities of the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e are equivalent to that of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e. In accordance with The Human Medicines Regulations (\u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e) regulation 182(2) (as amended by The Human Medicines (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019 (“the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit Regulations”)), the holder must:\u003c/p\u003e\n\n\u003cblockquote\u003e\n  \u003cp class=\"last-child\"\u003e(a) have permanently and continuously at its disposal an \u003ca href=\"https://www.gov.uk/government/publications/assessing-ordinary-residence-nationality-policy-guidance\" class=\"govuk-link\"\u003eappropriately qualified person responsible for pharmacovigilance who is ordinarily resident\u003c/a\u003e, and operates, in the United Kingdom and is responsible for the establishment and maintenance of the pharmacovigilance system.\u003c/p\u003e\n\u003c/blockquote\u003e\n\n\u003cp\u003eFurthermore, \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 12A (inserted by the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit Regulations) paragraph 10(4) states:\u003c/p\u003e\n\n\u003cblockquote\u003e\n  \u003cp class=\"last-child\"\u003eThe holder must ensure that the qualified person responsible for pharmacovigilance has sufficient authority to influence the performance of the quality system and the pharmacovigilance activities of the holder.\u003c/p\u003e\n\u003c/blockquote\u003e\n\n\u003cp\u003eFurther guidance on the qualifications and role of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e is described in \u003ca rel=\"external\" href=\"https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practices\" class=\"govuk-link\"\u003eGood Pharmacovigilance Practice (\u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e) Module I – Pharmacovigilance systems and their quality systems\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"temporary-exemption-as-to-the-location-of-the-uk-qppv\"\u003eTemporary exemption as to the location of the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eThere is a temporary exemption in place which allows you 21 months beginning with exit day to appoint a UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK. This is stated in \u003ca href=\"https://www.gov.uk/government/publications/further-guidance-note-on-the-regulation-of-medicines-medical-devices-and-clinical-trials-if-theres-no-brexit-deal/further-guidance-note-on-the-regulation-of-medicines-medical-devices-and-clinical-trials-if-theres-no-brexit-deal\" class=\"govuk-link\"\u003esection 1.9 of the further guidance from January 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eThis temporary exemption will allow the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who, immediately before exit day, resided and operated in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e state, to assume responsibility for UK authorised products until a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who resides and operates in the UK can be established.\u003c/p\u003e\n\n\u003cp\u003eA UK statutory instrument (SI) amending the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit Regulations has been laid and has received Parliamentary approval in both Houses. This amending SI clarifies that the temporary exemption as to the location of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e applies to holders of UK marketing authorisations or traditional herbal registrations that were granted before, on or after exit day, where:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003ethese UK marketing authorisations or traditional herbal registrations are included in the same pharmacovigilance system operated by the holder under regulation 182(1), and\u003c/li\u003e\n  \u003cli\u003ethe same \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e is responsible for this pharmacovigilance system.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"guidance-on-the-uk-psmf\"\u003eGuidance on the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003ch3 id=\"uk-psmf-location\"\u003eUK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e location\u003c/h3\u003e\n\n\u003cp\u003eYou need to ensure that the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e is located at the same point in the UK from which the reports of suspected adverse reactions referred to in \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e regulation 187(4) are accessible (electronically or physically). This differs from the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e concept where the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e shall be located either at the site where the main pharmacovigilance activities are performed or at the site where the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e operates.\u003c/p\u003e\n\n\u003cp\u003eThe UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e needs to be permanently and immediately available for inspection at the stated location in the UK.\u003c/p\u003e\n\n\u003ch3 id=\"uk-psmf-format-content-and-representation-of-pv-systems\"\u003eUK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e format, content and representation of \u003cabbr title=\"pharmacovigilance\"\u003ePV\u003c/abbr\u003e systems\u003c/h3\u003e\n\n\u003cp\u003eThe requirements for the format and content of the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e are equivalent to that of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e. The minimum requirements for the content and maintenance of the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e are laid out in \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 12A and further guidance on the format and content of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e is described in \u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e Module II – Pharmacovigilance system master file.\u003c/p\u003e\n\n\u003cp\u003eThe UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e must describe the global pharmacovigilance system and reflect the global availability of safety information for UK authorised products. The annex content should be specific to UK authorised products.\nAs per \u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e Module II, there are different approaches to establishing a pharmacovigilance system. For example:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e can establish more than one pharmacovigilance system.\u003c/li\u003e\n  \u003cli\u003eA pharmacovigilance system can be shared by several \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eYou must make sure that every pharmacovigilance system covering UK authorised products is identified by a unique number.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-request-a-uk-psmf-number\"\u003eHow to request a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number\u003c/h3\u003e\n\n\u003cp\u003eAll UK \u003cabbr title=\"pharmacovigilance system master files\"\u003ePSMFs\u003c/abbr\u003e must be registered with the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e. You should request a unique UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number from the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e for each pharmacovigilance system that you are operating for UK authorised products. Where the pharmacovigilance system is shared by several \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e, a single request for a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number should be submitted to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eA UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number can be requested via the \u003ca href=\"https://www.gov.uk/guidance/making-submissions-to-the-mhra-in-a-no-deal-scenario\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions Portal\u003c/a\u003e after exit day in a no deal Brexit scenario. You should follow the online instructions for requesting a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number and you should receive the number by email immediately upon completion of the online form.\u003c/p\u003e\n\n\u003cp\u003eYou are encouraged not to request the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number until the UK-resident \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e have been established.\u003c/p\u003e\n\n\u003ch2 id=\"temporary-exemption-in-relation-to-the-pharmacovigilance-system-master-file\"\u003eTemporary exemption in relation to the pharmacovigilance system master file\u003c/h2\u003e\n\n\u003cp\u003eA UK SI amending the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit Regulations has been laid and has received Parliamentary approval in both Houses. This amending SI introduces a temporary exemption in relation to the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e, which outlines that you will not need to maintain and make available on request of the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e a \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e covering UK authorised products until such time that a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK is established.\u003c/p\u003e\n\n\u003cp\u003eIn order to benefit from this temporary exemption, you must meet the following statutory conditions:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eYou are maintaining a complete and up-to-date \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and the pharmacovigilance system described within it is the same as that for your UK authorised products.\u003c/li\u003e\n  \u003cli\u003eThe \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products that resides and operates in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e state during the transitional period has permanent access to the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e.\u003c/li\u003e\n  \u003cli\u003eThe \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products that resides and operates in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e state during the transitional period has access to any other information concerning the compliance of the pharmacovigilance system with the legal requirements outlined in \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Part 11 and Schedule 12A.\u003c/li\u003e\n  \u003cli\u003eYou provide the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and the compliance information specified in the bullet point above to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e upon request.\n \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"notification-of-uk-qppv-and-psmf-details-to-the-mhra-by-existing-holders-of-uk-marketing-authorisations-ma\"\u003eNotification of UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e details to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e by existing holders of UK marketing authorisations (MA)\u003c/h2\u003e\n\n\u003cp\u003eAll UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e must include a summary of the holder’s pharmacovigilance system, including the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number. You should submit \u003ca href=\"https://www.gov.uk/guidance/medicines-apply-for-a-variation-to-your-marketing-authorisation\" class=\"govuk-link\"\u003eType IAIN variations\u003c/a\u003e related to the \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e and these submissions should cover all UK \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e under a unique pharmacovigilance system.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-make-your-submission\"\u003eHow to make your submission\u003c/h3\u003e\n\n\u003cp\u003eAll applications to update the \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e are required to be submitted as a Type IAIN - C.I.8.a variation via the \u003ca href=\"https://www.gov.uk/guidance/making-submissions-to-the-mhra-in-a-no-deal-scenario\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions portal\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eIn a no deal scenario we are expecting a large volume of regulatory submissions. You should submit your \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e updates as single changes and, to prevent delays, you should submit in collections of no more than 25 \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"documentation-you-need-to-supply\"\u003eDocumentation you need to supply\u003c/h3\u003e\n\n\u003cp\u003eYou should supply the following documentation in a C.I.8.a submission (Introduction of, or changes to, a summary of pharmacovigilance system for medical products for human use):\u003c/p\u003e\n\n\u003ch4 id=\"summary-of-the-pharmacovigilance-system-or-update-of-the-relevant-elements-as-applicable\"\u003e1. Summary of the pharmacovigilance system, or update of the relevant elements (as applicable):\u003c/h4\u003e\n\n\u003cul\u003e\n  \u003cli\u003eProof that the applicant has at his disposal a qualified person responsible for pharmacovigilance and a statement signed by the applicant to the effect that the applicant has the necessary means to fulfil the tasks and responsibilities listed in Part 11.\u003c/li\u003e\n  \u003cli\u003eContact details of the appropriately qualified person who is ordinarily resident and operates in the UK (or those of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e if this individual has assumed responsibility for UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e in the transitional period).\u003c/li\u003e\n  \u003cli\u003eA reference to the location where the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e for the medicinal product is kept or, if kept in electronic form, from which it can be accessed, which in either case must be in the United Kingdom (unless the UK-resident \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e have not been established yet, in which case the location of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be provided).\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch4 id=\"uk-psmf-number-if-the-uk-resident-qppv-and-the-uk-psmf-have-been-established\"\u003e2. UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number (if the UK-resident \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e have been established)\u003c/h4\u003e\n\n\u003cp\u003eFailing to supply all required documentation and information may lead to a rejection of the submission, which will require you to make a resubmission addressing all discrepancies. The requirements for various categories of variations are outlined in the guidelines published by the Commission under Article 4 of Regulation (EC) No 1234/2008. UK specific requirements regarding the summary of the pharmacovigilance system are outlined in \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 8.\u003c/p\u003e\n\n\u003ch3 id=\"submission-timeframes\"\u003eSubmission timeframes\u003c/h3\u003e\n\n\u003cp\u003eYou must notify the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e of changes to the \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e following any changes to the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products.\u003c/p\u003e\n\n\u003cp\u003eThe submission of \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e details for licences that were authorised via the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e centralised procedure should be handled differently to UK national licences. Please refer to this \u003cspan class=\"gem-c-attachment-link\"\u003e\n  \u003ca class=\"govuk-link\" href=\"https://assets.publishing.service.gov.uk/media/5e3957e4ed915d09378bf6d5/Submission_Timeframes_Overview.pdf\"\u003ediagram which has an overview of the timeframes for submitting SPS details to the MHRA\u003c/a\u003e  (\u003cspan class=\"gem-c-attachment-link__attribute\"\u003e\u003cabbr title=\"Portable Document Format\" class=\"gem-c-attachment-link__abbr\"\u003ePDF\u003c/abbr\u003e\u003c/span\u003e, \u003cspan class=\"gem-c-attachment-link__attribute\"\u003e575 KB\u003c/span\u003e, \u003cspan class=\"gem-c-attachment-link__attribute\"\u003e1 page\u003c/span\u003e)\u003c/span\u003e but further details for the different licence types are provided below.\u003c/p\u003e\n\n\u003ch4 id=\"guidance-relating-to-uk-national-licences-including-those-authorised-via-mutual-recognition-or-decentralised-procedures\"\u003eGuidance relating to UK national licences (including those authorised via mutual recognition or decentralised procedures)\u003c/h4\u003e\n\n\u003cp\u003eOn the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e, if the identity, location and contact details of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products are identical to that of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e immediately prior to exit day (as entered in the eXtended Eudravigilance Medicinal Product Dictionary, \u003cabbr title=\"eXtended Eudravigilance Medicinal Product Dictionary\"\u003eXEVMPD\u003c/abbr\u003e), no immediate action is required to notify the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eWithin two weeks of a change of identity, location or contact details of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products (either a change in the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e resident in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e State or the introduction of a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK), you should submit a single change Type IAIN - C.I.8.a variation covering all UK \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e under a unique pharmacovigilance system (in collections of no more than 25 \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e).\u003c/p\u003e\n\n\u003cp\u003eA \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK must be established within 21 months of exit day. If there is no change to the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e details from those entered on \u003cabbr title=\"eXtended Eudravigilance Medicinal Product Dictionary\"\u003eXEVMPD\u003c/abbr\u003e, then these details for the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e, together with the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e location and number, should be submitted as a single change Type IAIN - C.I.8.a variation before this deadline.\u003c/p\u003e\n\n\u003ch4 id=\"licences-authorised-via-the-eu-centralised-procedure\"\u003eLicences authorised via the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e centralised procedure\u003c/h4\u003e\n\n\u003cp\u003eAll existing \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e authorised through the centrally authorised procedure will automatically be converted into UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e and issued with a UK MA number on exit day, in a no deal scenario.\u003c/p\u003e\n\n\u003cp\u003eYou will have a period of one year, starting on exit day, to submit the initiating sequence data and related information \u003ca rel=\"external\" href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/768214/MHRA_CAP_conversion_letter_and_guidance.pdf\" class=\"govuk-link\"\u003ein eCTD format\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eFollowing submission of the initiating eCTD sequence and receipt of the approval letter from the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cp\u003eIf the identity, location and contact details of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products are identical to that of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e immediately prior to exit day (as entered in \u003cabbr title=\"eXtended Eudravigilance Medicinal Product Dictionary\"\u003eXEVMPD\u003c/abbr\u003e), no immediate action is required to notify the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e. Within two weeks of a change of identity, location or contact details of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products (either a change in the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e resident in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e State or the introduction of a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK), you should submit a single change Type IAIN - C.I.8.a variation covering all UK (ex-\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e) \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e under a unique pharmacovigilance system (in collections of no more than 25 \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e)\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eIf the identity, location or contact details of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e responsible for UK authorised products are different to that entered in \u003cabbr title=\"eXtended Eudravigilance Medicinal Product Dictionary\"\u003eXEVMPD\u003c/abbr\u003e (either a change in the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e resident in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e State or the introduction of a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that resides and operates in the UK), you should submit a single change Type IAIN - C.I.8.a variation covering all UK (ex-\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e) \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e under a unique pharmacovigilance system (in collections of no more than 25 \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e)\u003c/p\u003e\n  \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"guidance-for-applicants-for-uk-mas\"\u003eGuidance for applicants for UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003cp\u003eAs per \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 8, the material to accompany an application for a UK marketing authorisation includes a summary of the applicant’s pharmacovigilance system which must include the following elements:\u003c/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eproof that the applicant has at the applicant’s disposal an appropriately qualified person responsible for pharmacovigilance who is ordinarily resident, and operates, in the United Kingdom (or in an \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e State if the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e has assumed responsibility for UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e in the transitional period)\u003c/li\u003e\n  \u003cli\u003ethe contact details of the appropriately qualified person\u003c/li\u003e\n  \u003cli\u003ea statement signed by the applicant to the effect that the applicant has the necessary means to fulfil the tasks and responsibilities listed in Part 11\u003c/li\u003e\n  \u003cli\u003ea reference to the location where the pharmacovigilance system master file for the medicinal product is kept or, if kept in electronic form, from which it can be accessed, which in either case must be in the United Kingdom (unless the UK-resident \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e have not been established yet, in which case the location of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be provided)\u003c/li\u003e\n\u003c/ol\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Summary of pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e should also include the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number (if the UK-resident \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e have been established).\u003c/p\u003e\n\n\u003cp\u003eGuidance on the application process \u003ca href=\"https://www.gov.uk/guidance/apply-for-a-licence-to-market-a-medicine-in-the-uk#application-process-all-procedures\" class=\"govuk-link\"\u003eis available\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"queries\"\u003eQueries\u003c/h2\u003e\n\n\u003cp\u003eGeneral queries relating to the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e, UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and establishment of pharmacovigilance systems for UK authorised products should be sent to: \u003ca href=\"mailto:gpvpinspectors@mhra.gov.uk\" class=\"govuk-link\"\u003egpvpinspectors@mhra.gov.uk\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eQueries relating to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number should be sent to: \u003ca href=\"mailto:UKPSMFadmin@mhra.gov.uk\" class=\"govuk-link\"\u003eUKPSMFadmin@mhra.gov.uk\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eQueries relating to submission of Type IA variations should be sent to: \u003ca href=\"mailto:variationqueries@mhra.gov.uk\" class=\"govuk-link\"\u003evariationqueries@mhra.gov.uk\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Added new section about the temporary exemption in relation to the pharmacovigilance system master file. Added information about requesting a UK PSMF number via the MHRA Submissions portal.  ",
                                               "public_timestamp":  "2019-10-11T15:49:11.000+01:00"
                                           },
                                           {
                                               "note":  "Change of text within Stay up to date box.",
                                               "public_timestamp":  "2019-10-09T12:35:59.000+01:00"
                                           },
                                           {
                                               "note":  "We have removed some outdated background information and made changes to emphasise the actions Marketing Authorisation holders will need to take.",
                                               "public_timestamp":  "2019-08-07T14:58:04.000+01:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2019-03-12T12:12:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2019-03-12T12:12:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2019-03-12T12:12:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf-if-the-uk-leaves-the-eu-w",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf-if-the-uk-leaves-the-eu-w",
                                                     "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf-if-the-uk-leaves-the-eu-w",
                                                     "content_id":  "9ab63128-495b-494f-8c43-b317f1fa5efc",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2019-10-11T14:49:11Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF) in a no-deal Brexit",
                                                     "web_url":  "https://www.gov.uk/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf-if-the-uk-leaves-the-eu-w",
                                                     "withdrawn":  true
                                                 }
                                             ],
                  "facet_groups":  [
                                       {
                                           "content_id":  "52435175-82ed-4a04-adef-74c0199d0f46",
                                           "document_type":  "facet_group",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:54Z",
                                           "schema_name":  "facet_group",
                                           "title":  "Find EU Exit guidance business",
                                           "withdrawn":  false
                                       }
                                   ],
                  "facet_values":  [
                                       {
                                           "content_id":  "93f5c156-2449-4e52-9e92-aefc73586ffd",
                                           "document_type":  "facet_value",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:58Z",
                                           "schema_name":  "facet_value",
                                           "title":  "Pharmaceuticals and clinical trials",
                                           "withdrawn":  false
                                       }
                                   ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "content_id":  "326e92c5-253d-4ab9-bdef-bffa0985fa7b",
                                     "details":  {
                                                     "internal_name":  "Good practice, inspections and enforcement [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:21Z",
                                     "schema_name":  "taxon",
                                     "title":  "Good practice, inspections and enforcement",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "content_id":  "49f5ab15-d6fe-4a8e-8e56-44878798e7d6",
                                     "details":  {
                                                     "internal_name":  "Vigilance, safety alerts and guidance [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:18Z",
                                     "schema_name":  "taxon",
                                     "title":  "Vigilance, safety alerts and guidance",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2019-10-11T15:49:11+01:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1713893569.856-10.13.28.206-628",
    "publishing_scheduled_at":  null,
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  null,
    "schema_name":  "detailed_guide",
    "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF) in a no-deal Brexit",
    "updated_at":  "2024-11-14T17:48:58+00:00",
    "withdrawn_notice":  {
                             "explanation":  "\u003cdiv class=\"govspeak\"\u003e\u003cp\u003eFor current information on qualified person responsible for pharmacovigilance (QPPV) see \u003ca rel=\"external\" href=\"https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance/legal-framework-pharmacovigilance\" class=\"govuk-link\"\u003eEuropean Medicines Agency: Legal framework: Pharmacovigilance\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e",
                             "withdrawn_at":  "2020-02-24T11:19:29Z"
                         }
}
